Response to: Lavey, RS et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IB-IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol. Oncol. 95 (2004) 145-151.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples